Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 21;7(43):38311-38321.
doi: 10.1021/acsomega.2c02714. eCollection 2022 Nov 1.

In Silico Investigations into the Selectivity of Psychoactive and New Psychoactive Substances in Monoamine Transporters

Affiliations

In Silico Investigations into the Selectivity of Psychoactive and New Psychoactive Substances in Monoamine Transporters

Michelle J Botha et al. ACS Omega. .

Abstract

New psychoactive substances (NPS) are a group of compounds that mimic the effects of illicit substances. A range of NPS have been shown to interact with the three main classes of monoamine transporters (DAT, NET, and SERT) to differing extents, but it is unclear why these differences arise. To aid in understanding the differences in affinity between the classes of monoamine transporters, several in silico experiments were conducted. Docking experiments showed there was no direct correlation between a range of scoring functions and experimental activity, but Spearman ranking analysis showed a significant correlation (α = 0.1) for DAT, with the affinity ΔG (0.42), αHB (0.40), GoldScore (0.40), and PLP (0.41) scoring functions, and for DAT (0.38) and SERT (0.40) using a consensus scoring approach. Qualitative structure-activity relationship (QSAR) experiments resulted in the generation of robust and predictive three-descriptor models for SERT (r 2 = 0.87, q 2 = 0.8, and test set r 2 = 0.74) and DAT (r 2 = 0.68, q 2 = 0.51, test set r 2 = 0.63). Both QSAR models described similar characteristics for binding, i.e., rigid hydrophobic molecules with a biogenic amine moiety, and were not sufficient to facilitate a deeper understanding of differences in affinity between the monoamine transporters. This contextualizes the observed promiscuity for NPS between the isoforms and highlights the difficulty in the design and development of compounds that are isoform-selective.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Figure 1
Figure 1
Overlaid putative binding sites of the DAT (green), NET (white), and SERT (magenta) MAT homology models illustrating the similarities in the size and shape of the putative binding cavities.
Figure 2
Figure 2
Superimposed Ca traces of 4M48 (blue), Q01959 (DAT, green), P23975 (NET, white), and P31645 (SERT, magenta) illustrating a conserved tertiary structure with variations in loop regions.
Figure 3
Figure 3
(A) Overlaid binding sites of P31645 (green) and 5I6X (magenta) with docked fluoxetine (black ball and stick and cyan ball and stick, respectively) showing differences in ligand position. (B) Overlaid binding sites of P31645 (orange) and 5I6X (purple) illustrating the variation in side-chain conformation. Co-complexed s-citalopram (black stick model) from 5I6X is shown for reference.

Similar articles

Cited by

References

    1. Richelson E. Interactions of Antidepressants With Neurotransmitter Transporters and Receptors and Their Clinical Relevance. J. Clin. Psychiatry 2003, 64 (Suppl 13), 5–12. - PubMed
    1. Lin Z.; Canales J. J.; Björgvinsson T.; Thomsen M.; Qu H.; Liu Q.-R.; Torres G. E.; Caine S. B. Monoamine Transporters: Vulnerable and Vital Doorkeepers. Prog. Mol. Biol. Trans. Sci. 2011, 98, 1–46. 10.1016/B978-0-12-385506-0.00001-6. - DOI - PMC - PubMed
    1. Howell L. L.; Kimmel H. L. Monoamine Transporters and Psychostimulant Addiction. Biochem. Pharmacol. 2008, 75 (1), 196–217. 10.1016/j.bcp.2007.08.003. - DOI - PubMed
    1. Kristensen A. S.; Andersen J.; Jørgensen T. N.; Sørensen L.; Eriksen J.; Loland C. J.; Strømgaard K.; Gether U. SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation. Pharmacol Rev. 2011, 63 (3), 585–640. 10.1124/pr.108.000869. - DOI - PubMed
    1. Torres G. E.; Gainetdinov R. R.; Caron M. G. Plasma Membrane Monoamine Transporters: Structure, Regulation and Function. Nat. Rev. Neurosci 2003, 4 (1), 13–25. 10.1038/nrn1008. - DOI - PubMed